{"id":10,"date":"2022-02-21T00:43:35","date_gmt":"2022-02-20T19:13:35","guid":{"rendered":"https:\/\/thetrustedchronicle.com\/?p=10"},"modified":"2022-02-21T00:43:39","modified_gmt":"2022-02-20T19:13:39","slug":"cardiac-safety-services-market-size-share-top-key-players-growth-trend-and-forecast-till-2027","status":"publish","type":"post","link":"https:\/\/thetrustedchronicle.com\/ca\/cardiac-safety-services-market-size-share-top-key-players-growth-trend-and-forecast-till-2027\/","title":{"rendered":"Cardiac Safety Services Market Size, Share, Top Key Players, Growth, Trend and Forecast Till 2027"},"content":{"rendered":"
\n
\n \t<\/i> Read Time:<\/span>4 Minute, 22 Second <\/div>\n\n <\/div>\n

The rising incidences of Cardiovascular disorders, improved technological advances, rising prevalence of heart-related diseases, rising geriatric population, new product launches, and strategic collaboration, are key factors contributing to the high CAGR of the Cardiac Safety Services market during the forecast period.<\/p>\n\n\n\n

Market Size \u2013 USD 384.9 Million in 2018, Market Growth \u2013 CAGR of 11 % Market Trends\u2013 Favorable government funding scenario.<\/p>\n\n\n\n

According to the current analysis of Reports and Data, the global Cardiac Safety Services Market valued at USD 384.9 million in 2018 and is expected to reach USD 895.7 million by the year 2026, at a CAGR of 11%. Cardiac safety is the primary cause of the Clinical trial delay and drug abandonment. Cardiac Safety services are beneficial for monitoring the abnormalities of the heart. There has been a significant rise in the R&D expenditure in the pharmaceutical & biopharmaceutical industry and increased R&D activities. The increase in the number of clinical trials is fuelling the growth of the market. Additionally, the advances of the new technologies in the cardiac services market are offering growth opportunities for players in the market. However, the high expenditure cost of cardiac safety evaluation is hindering the growth of the market.<\/p>\n\n\n\n

American college of cardiology has reported in the year 2019 that Cardiovascular disease (CVD) is the primary cause of death in the United States and is responsible for 840,768 deaths in 2016. From 2006 \u2013 2016, the U.S. death rate from cardiovascular disorders have decreased by 18.6% and from coronary heart disease by 31.8%.<\/p>\n\n\n\n

Get a sample of the report @ <\/strong>https:\/\/www.reportsanddata.com\/sample-enquiry-form\/2707  <\/strong><\/p>\n\n\n\n

The report provides a complete coverage of the recent mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others. To offer a clear understanding of the scope of the industry, competitive landscape and different progressive aspects are studied extensively in the report.<\/p>\n\n\n\n

Key companies operating in the global market and profiled in the report include:<\/strong><\/p>\n\n\n\n

Biotrial (France), Banook Group (France & Canada), Bioclinica (a subsidiary of Cinven, US), Certara L.P. (U.S.), Celerion, Inc. (U.S.), ERT, Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), Medpace Holdings, Inc. (U.S.), Ncardia AG (Belgium), Richmond Pharmacology (U.K.), PhysioStim (France), Shanghai Medicilon Inc. (China), Pharmaceutical Product Development LLC (U.S.), SGS S.A. (Switzerland), BioTelemetry, Inc. (U.S.), IQVIA (U.S.), OMRON Healthcare, Inc (Japan), Biobeat (U.S.) and InBody USA (U.S.), Microsoft (U.S.)<\/p>\n\n\n\n

The report further offers insights into company overviews, business landscape, production and manufacturing capacity, product portfolio, financial standing, global market position, gross profit margins, SWOT analysis and Porter\u2019s Five Forces analysis for each company. The report also covers feasibility analysis and investment return analysis to offer deeper insights into market landscape and industrial chain.<\/p>\n\n\n\n

Cardiac Safety Services Market Segmentation:<\/strong><\/p>\n\n\n\n

Type Outlook:<\/strong><\/p>\n\n\n\n

Product and Services <\/strong>Outlook (Revenue in Million USD; 2017\u20132024)<\/strong><\/p>\n\n\n\n